Cargando…
Shorter TB treatment regimens should be safer as well
Most ongoing and planned TB therapeutic trials are focused on shortening the duration of treatment while giving less consideration to other aspects of TB care that are important to people with TB. Here we argue that other variables besides duration of TB treatment should also be considered when deve...
Autores principales: | Rucsineanu, O., Agbassi, P., Herrera, R., Low, M., McKenna, L., Stillo, J., Winarni, P., Acharya, A., Sari, A. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Union Against Tuberculosis and Lung Disease
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10446660/ https://www.ncbi.nlm.nih.gov/pubmed/37736577 http://dx.doi.org/10.5588/pha.23.0026 |
Ejemplares similares
-
One size does not fit all: community views on choices for TB treatment and prevention
por: Makone, A., et al.
Publicado: (2023) -
Drug-resistant tuberculosis: Progress towards shorter and safer regimens
por: Saravu, Kavitha, et al.
Publicado: (2019) -
High success and low recurrence with shorter treatment regimen for multidrug-resistant TB in Nepal
por: Koirala, S., et al.
Publicado: (2021) -
Prospective study on outcome of MDR-TB using the shorter regimen during COVID-19 pandemic
por: Kumar, G Sravan, et al.
Publicado: (2023) -
Limited Scope of Shorter Drug Regimen for MDR TB Caused by High Resistance to Fluoroquinolone
por: Singh, Pravin K., et al.
Publicado: (2019)